Skip to content

Preoxygenation Using THRIVE Versus Facemask in Parturients

Preoxygenation Using THRIVE and Facemask Oxygenation in Parturients

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03772574
Enrollment
91
Registered
2018-12-11
Start date
2018-12-01
Completion date
2020-04-24
Last updated
2022-05-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Preoxygenation

Brief summary

This study aims to determine the duration for pre-oxygenation using THRIVE and facemask for parturients.

Detailed description

We aim to determine the duration required for THRIVE and facemask preoxygenation in parturients for them to achieve ETO2 \>90%.

Interventions

DEVICEFacemask preoxygenation

Standard facemask preoxygenation

DEVICETHRIVE preoxygenation

Preoxygenation using transnasal humidified rapid insufflation ventilatory exchange (THRIVE).

Sponsors

University of British Columbia
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
19 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Pregnant patients ≥36 weeks gestation. * Non-laboring patients admitted for elective Cesarean delivery under neuraxial anesthesia or induction of labor. * American Society of Anesthesiologists (ASA) class 2.

Exclusion criteria

* Any medical conditions that are likely to affect gas exchange. * Obstructed nasal passage. * Unable to tolerate a tight fitting facemask. * Body Mass Index ≥40 kg/m2. * Patients who are in active labor (i.e. cervical dilation ≥4cm). * Patients who are unable to give informed consent.

Design outcomes

Primary

MeasureTime frameDescription
Preoxygenation DurationMaximum 8 minutesDuration to achieve EtO2 \>=90% after tidal volume breathing using THRIVE and facemask pre-oxygenation.

Secondary

MeasureTime frameDescription
Proportion to Reach End Tidal Oxygen (ETO2) of 90 Percent at 3 Minutes3 minutes of pre-oxygenation
Proportion to Reach EtO2 of 90 Percent at 4 Minutes4 minutes of preoxygenation
Proportion to Reach EtO2 of 90 Percent at 5 Minutes5 minutes of preoxygenation
Proportion to Reach EtO2 of 90 Percent at 8 Minutes8 minutes of preoxygenation
Proportion to Reach EtO2 of 90 Percent at 7 Minutes7 minutes of preoxygenation
Comfort Score1 minute after data collectionPatients were asked to rate their comfort with the device on a 5 point Likert Scale: (1=completely uncomfortable, 2=slightly uncomfortable, 3=neutral, 4=slightly comfortable, 5= completely comfortable)
Acceptability Score1 minute after data collectionAcceptability was measured with a 5-point Likert Score (1= unacceptable, 2=slightly unacceptable,3=neutral, 4=slightly acceptable, 5=acceptable).
Proportion to Reach EtO2 of 90 Percent at 6 Minutes6 minutes of preoxygenation

Countries

Canada

Participant flow

Pre-assignment details

91 patients provided informed consent in order to reach the recruitment goal of 80 patients. This is the reason for the discrepancy mentioned in the comments.

Participants by arm

ArmCount
Standard Facemask
Facemask preoxygenation (tidal volume breathing via a face mask set at 100% oxygen). Facemask preoxygenation: Standard facemask preoxygenation
40
THRIVE
THRIVE preoxygenation (tidal volume breathing with the OptiFlow system applied at 100% oxygen). THRIVE preoxygenation: Preoxygenation using transnasal humidified rapid insufflation ventilatory exchange (THRIVE).
20
THRIVE and Facemask
THRIVE preoxygenation (tidal volume breathing with the OptiFlow system applied at 100% oxygen). Facemask used to minimize air entrainment THRIVE preoxygenation: Preoxygenation using transnasal humidified rapid insufflation ventilatory exchange (THRIVE).
20
Total80

Withdrawals & dropouts

PeriodReasonFG000FG001FG002
Overall StudyDiscomfort054
Overall StudyProtocol Violation200

Baseline characteristics

CharacteristicTHRIVE and FacemaskStandard FacemaskTotalTHRIVE
Age, Continuous35 years
STANDARD_DEVIATION 4.4
35.5 years
STANDARD_DEVIATION 4.3
35.3 years
STANDARD_DEVIATION 4.2
35 years
STANDARD_DEVIATION 4.1
Baseline End Tidal Oxygen (ETO2)15.8 Percent of oxygen in expired breath
STANDARD_DEVIATION 1
15.7 Percent of oxygen in expired breath
STANDARD_DEVIATION 1.2
15.7 Percent of oxygen in expired breath
STANDARD_DEVIATION 1.1
15.7 Percent of oxygen in expired breath
STANDARD_DEVIATION 0.9
Baseline Heart Rate75.2 bpm
STANDARD_DEVIATION 13.9
74.4 bpm
STANDARD_DEVIATION 10.8
75.1 bpm
STANDARD_DEVIATION 11.3
76.1 bpm
STANDARD_DEVIATION 9.7
Baseline Oxygen Saturation (SPO2)98.5 percent of hemoglobin carrying oxygen
STANDARD_DEVIATION 1.4
98.0 percent of hemoglobin carrying oxygen
STANDARD_DEVIATION 1.5
98.2 percent of hemoglobin carrying oxygen
STANDARD_DEVIATION 1.4
98.4 percent of hemoglobin carrying oxygen
STANDARD_DEVIATION 1.4
Baseline respiratory rate13.3 breaths/min
STANDARD_DEVIATION 3.1
11.9 breaths/min
STANDARD_DEVIATION 3.7
12.9 breaths/min
STANDARD_DEVIATION 3.8
14.5 breaths/min
STANDARD_DEVIATION 4.1
BMI30.4 kg/m^2
STANDARD_DEVIATION 3.8
29.1 kg/m^2
STANDARD_DEVIATION 3.7
29.5 kg/m^2
STANDARD_DEVIATION 4
29.5 kg/m^2
STANDARD_DEVIATION 4.8
Gestational age39.1 weeks
STANDARD_DEVIATION 0.6
38.6 weeks
STANDARD_DEVIATION 1
38.8 weeks
STANDARD_DEVIATION 0.92
38.7 weeks
STANDARD_DEVIATION 1.1
Gravidity2 Pregnancies2 Pregnancies2 Pregnancies2 Pregnancies
Parity1 births1 births1 births1 births
Race and Ethnicity Not Collected0 Participants
Region of Enrollment
Canada
20 participants40 participants80 participants20 participants
Sex: Female, Male
Female
20 Participants40 Participants80 Participants20 Participants
Sex: Female, Male
Male
0 Participants0 Participants0 Participants0 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
deaths
Total, all-cause mortality
0 / 420 / 250 / 24
other
Total, other adverse events
0 / 420 / 250 / 24
serious
Total, serious adverse events
0 / 420 / 250 / 24

Outcome results

Primary

Preoxygenation Duration

Duration to achieve EtO2 \>=90% after tidal volume breathing using THRIVE and facemask pre-oxygenation.

Time frame: Maximum 8 minutes

ArmMeasureValue (MEAN)
Standard FacemaskPreoxygenation Duration3.6 minutes
THRIVEPreoxygenation DurationNA minutes
THRIVE and FacemaskPreoxygenation DurationNA minutes
Secondary

Acceptability Score

Acceptability was measured with a 5-point Likert Score (1= unacceptable, 2=slightly unacceptable,3=neutral, 4=slightly acceptable, 5=acceptable).

Time frame: 1 minute after data collection

ArmMeasureValue (MEDIAN)
Standard FacemaskAcceptability Score5 Likert Score
THRIVEAcceptability Score4.5 Likert Score
THRIVE and FacemaskAcceptability Score5 Likert Score
Secondary

Comfort Score

Patients were asked to rate their comfort with the device on a 5 point Likert Scale: (1=completely uncomfortable, 2=slightly uncomfortable, 3=neutral, 4=slightly comfortable, 5= completely comfortable)

Time frame: 1 minute after data collection

ArmMeasureValue (MEDIAN)
Standard FacemaskComfort Score4 Likert Score
THRIVEComfort Score4 Likert Score
THRIVE and FacemaskComfort Score4 Likert Score
Secondary

Proportion to Reach End Tidal Oxygen (ETO2) of 90 Percent at 3 Minutes

Time frame: 3 minutes of pre-oxygenation

Population: Patients selected to receive 3 minutes of pre-oxygenation

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Standard FacemaskProportion to Reach End Tidal Oxygen (ETO2) of 90 Percent at 3 Minutes10 Participants
THRIVEProportion to Reach End Tidal Oxygen (ETO2) of 90 Percent at 3 Minutes0 Participants
THRIVE and FacemaskProportion to Reach End Tidal Oxygen (ETO2) of 90 Percent at 3 Minutes0 Participants
Secondary

Proportion to Reach EtO2 of 90 Percent at 4 Minutes

Time frame: 4 minutes of preoxygenation

Population: Patients assigned to recieve 4 minutes of pre-oxygenation

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Standard FacemaskProportion to Reach EtO2 of 90 Percent at 4 Minutes26 Participants
THRIVEProportion to Reach EtO2 of 90 Percent at 4 Minutes2 Participants
THRIVE and FacemaskProportion to Reach EtO2 of 90 Percent at 4 Minutes4 Participants
Secondary

Proportion to Reach EtO2 of 90 Percent at 5 Minutes

Time frame: 5 minutes of preoxygenation

Population: Patients assigned to receive 5 minutes of pre-oxygenation

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Standard FacemaskProportion to Reach EtO2 of 90 Percent at 5 Minutes0 Participants
THRIVEProportion to Reach EtO2 of 90 Percent at 5 Minutes0 Participants
THRIVE and FacemaskProportion to Reach EtO2 of 90 Percent at 5 Minutes0 Participants
Secondary

Proportion to Reach EtO2 of 90 Percent at 6 Minutes

Time frame: 6 minutes of preoxygenation

Population: Patients assigned to receive 6 minutes of preoxygenation

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
THRIVEProportion to Reach EtO2 of 90 Percent at 6 Minutes0 Participants
THRIVE and FacemaskProportion to Reach EtO2 of 90 Percent at 6 Minutes0 Participants
Secondary

Proportion to Reach EtO2 of 90 Percent at 7 Minutes

Time frame: 7 minutes of preoxygenation

Population: Patients assigned to receive 7 minutes of preoxygenation

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Standard FacemaskProportion to Reach EtO2 of 90 Percent at 7 Minutes0 Participants
THRIVEProportion to Reach EtO2 of 90 Percent at 7 Minutes0 Participants
THRIVE and FacemaskProportion to Reach EtO2 of 90 Percent at 7 Minutes0 Participants
Secondary

Proportion to Reach EtO2 of 90 Percent at 8 Minutes

Time frame: 8 minutes of preoxygenation

Population: patients assigned to receive 8 minuets of pre-oxygenation

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Standard FacemaskProportion to Reach EtO2 of 90 Percent at 8 Minutes0 Participants
THRIVEProportion to Reach EtO2 of 90 Percent at 8 Minutes1 Participants
THRIVE and FacemaskProportion to Reach EtO2 of 90 Percent at 8 Minutes5 Participants

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026